Literature DB >> 8286199

E-cadherin expression in basal cell carcinoma.

A Pizarro1, N Benito, P Navarro, J Palacios, A Cano, M Quintanilla, F Contreras, C Gamallo.   

Abstract

E-cadherin (E-CD) is a calcium-dependent cell-cell adhesion molecule which is expressed in almost all epithelial tissues. E-CD expression is involved in epidermal morphogenesis and is reduced during tumour progression of mouse epidermal carcinogenesis. It has been suggested that E-CD could play a role as an invasion-suppressor molecule. In the present work we have studied the E-CD expression in 31 patients with basal cell carcinoma (BCC) using an immunohistochemical technique with a monoclonal antibody (HECD-1) specific for human E-CD. E-CD expression was preserved in all specimens of superficial and nodular BCC, and was reduced in 10 of 15 infiltrative BCCs. A heterogeneous distribution of cells with different immunostaining intensity was more frequently observed in specimens of infiltrative BCC. These results suggest that E-CD might be related to the growth pattern and the local aggressive behaviour of BCC, and support the idea that E-CD might play a role as an invasion-suppressor molecule in vivo.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8286199      PMCID: PMC1968779          DOI: 10.1038/bjc.1994.26

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  46 in total

1.  Adhesion molecules and related proteins in Darier's disease and Hailey-Hailey disease.

Authors:  S M Burge; K H Schomberg
Journal:  Br J Dermatol       Date:  1992-10       Impact factor: 9.302

2.  Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role.

Authors:  K Vleminckx; L Vakaet; M Mareel; W Fiers; F van Roy
Journal:  Cell       Date:  1991-07-12       Impact factor: 41.582

3.  E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis.

Authors:  J H Schipper; U H Frixen; J Behrens; A Unger; K Jahnke; W Birchmeier
Journal:  Cancer Res       Date:  1991-12-01       Impact factor: 12.701

4.  Infiltrative basal cell carcinoma: a nonsclerosing subtype.

Authors:  R J Siegle; J MacMillan; S V Pollack
Journal:  J Dermatol Surg Oncol       Date:  1986-08

Review 5.  Molecular aspects of tumor cell invasion and metastasis.

Authors:  S Aznavoorian; A N Murphy; W G Stetler-Stevenson; L A Liotta
Journal:  Cancer       Date:  1993-02-15       Impact factor: 6.860

6.  Down-regulation of E-cadherin expression in Madin Darby canine kidney (MDCK) cells inside tumors of nude mice.

Authors:  M M Mareel; J Behrens; W Birchmeier; G K De Bruyne; K Vleminckx; A Hoogewijs; W C Fiers; F M Van Roy
Journal:  Int J Cancer       Date:  1991-04-01       Impact factor: 7.396

7.  Cadherin intercellular adhesion molecule in hepatocellular carcinomas: loss of E-cadherin expression in an undifferentiated carcinoma.

Authors:  Y Shimoyama; S Hirohashi
Journal:  Cancer Lett       Date:  1991-05-01       Impact factor: 8.679

Review 8.  Biology of basal cell carcinoma (Part I).

Authors:  S J Miller
Journal:  J Am Acad Dermatol       Date:  1991-01       Impact factor: 11.527

9.  Expression and role of E- and P-cadherin adhesion molecules in embryonic histogenesis. II. Skin morphogenesis.

Authors:  Y Hirai; A Nose; S Kobayashi; M Takeichi
Journal:  Development       Date:  1989-02       Impact factor: 6.868

10.  Regulation of keratinocyte intercellular junction organization and epidermal morphogenesis by E-cadherin.

Authors:  M J Wheelock; P J Jensen
Journal:  J Cell Biol       Date:  1992-04       Impact factor: 10.539

View more
  12 in total

1.  Loss of E-cadherin expression associated with lymph node metastases in small breast carcinomas.

Authors:  N C Hunt; A G Douglas-Jones; B Jasani; J M Morgan; M Pignatelli
Journal:  Virchows Arch       Date:  1997-04       Impact factor: 4.064

2.  Snail induction is an early response to Gli1 that determines the efficiency of epithelial transformation.

Authors:  X Li; W Deng; C D Nail; S K Bailey; M H Kraus; J M Ruppert; S M Lobo-Ruppert
Journal:  Oncogene       Date:  2006-01-26       Impact factor: 9.867

3.  Distribution of E-cadherin and Ep-CAM in the human lung during development and after injury.

Authors:  M Kasper; J Behrens; D Schuh; M Müller
Journal:  Histochem Cell Biol       Date:  1995-04       Impact factor: 4.304

4.  Immunocytochemical distribution of E-cadherin in normal and injured lung tissue of the rat.

Authors:  M Kasper; O Huber; H Grossmann; B Rudolph; C Tränkner; M Müller
Journal:  Histochem Cell Biol       Date:  1995-11       Impact factor: 4.304

5.  Regulation of matrilysin expression in cells of squamous cell carcinoma by E-cadherin-mediated cell-cell contact.

Authors:  A H Borchers; L A Sanders; G T Bowden
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

Review 6.  Regulation of E-cadherin: does hypoxia initiate the metastatic cascade?

Authors:  I R Beavon
Journal:  Mol Pathol       Date:  1999-08

7.  Anomalous expression of P-cadherin in breast carcinoma. Correlation with E-cadherin expression and pathological features.

Authors:  J Palacios; N Benito; A Pizarro; A Suárez; J Espada; A Cano; C Gamallo
Journal:  Am J Pathol       Date:  1995-03       Impact factor: 4.307

8.  Relationship between ERBB2 and E-cadherin expression in human breast cancer.

Authors:  J Palacios; N Benito; A Pizarro; M A Limeres; A Suárez; A Cano; C Gamallo
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

Review 9.  Adhesion Molecules in Non-melanoma Skin Cancers: A Comprehensive Review.

Authors:  Joanna Pogorzelska-Dyrbus; Jacek C Szepietowski
Journal:  In Vivo       Date:  2021-04-28       Impact factor: 2.406

10.  Differential patterns of placental and epithelial cadherin expression in basal cell carcinoma and in the epidermis overlying tumours.

Authors:  A Pizarro; C Gamallo; N Benito; J Palacios; M Quintanilla; A Cano; F Contreras
Journal:  Br J Cancer       Date:  1995-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.